Range Financial Group LLC bought a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,930 shares of the company’s stock, valued at approximately $117,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Canada Pension Plan Investment Board purchased a new stake in shares of Nu Skin Enterprises in the 2nd quarter worth $47,000. Headlands Technologies LLC increased its holdings in Nu Skin Enterprises by 1,428.0% in the 2nd quarter. Headlands Technologies LLC now owns 6,937 shares of the company’s stock worth $73,000 after acquiring an additional 6,483 shares in the last quarter. Covestor Ltd raised its stake in Nu Skin Enterprises by 110.9% during the 3rd quarter. Covestor Ltd now owns 10,140 shares of the company’s stock worth $75,000 after acquiring an additional 5,333 shares during the period. Gladius Capital Management LP purchased a new position in Nu Skin Enterprises during the third quarter valued at approximately $77,000. Finally, Versor Investments LP bought a new position in shares of Nu Skin Enterprises in the third quarter worth approximately $86,000. 82.84% of the stock is owned by hedge funds and other institutional investors.
Nu Skin Enterprises Price Performance
Shares of Nu Skin Enterprises stock opened at $6.87 on Wednesday. The firm has a market cap of $341.51 million, a PE ratio of -3.32 and a beta of 1.19. The stock has a 50 day moving average of $7.11 and a 200 day moving average of $8.22. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises, Inc. has a 12 month low of $5.95 and a 12 month high of $19.30.
Nu Skin Enterprises Announces Dividend
Analysts Set New Price Targets
A number of brokerages have issued reports on NUS. Citigroup cut their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research note on Tuesday, October 22nd. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. Finally, DA Davidson reduced their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th.
View Our Latest Stock Analysis on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Recommended Stories
- Five stocks we like better than Nu Skin Enterprises
- 3 Warren Buffett Stocks to Buy Now
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What is the Nikkei 225 index?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.